Fin Trust Capital Advisors, LLC Gsk PLC Transaction History

Fin Trust Capital Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$42.05 - $47.77 $51,763 - $58,804	-1,231 Reduced 25.2%	3,653 $154,000
Q1 2022 May 03, 2022	SELL	$40.23 - $47.74 $6,517 - $7,733	-162 Reduced 3.21%	4,884 $213,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $45,800 - $53,375	1,178 Added 30.46%	5,046 $223,000
Q3 2021 Nov 16, 2021	SELL	$38.79 - $43.16 $9,038 - $10,056	-233 Reduced 5.68%	3,868 $148,000
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $21,510 - $24,419	589 Added 16.77%	4,101 $163,000
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $5,071 - $5,921	-148 Reduced 4.04%	3,512 $125,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $9,198 - $10,783	-270 Reduced 6.87%	3,660 $135,000
Q3 2020 Nov 10, 2020	SELL	$38.11 - $42.99 $29,954 - $33,790	-786 Reduced 16.67%	3,930 $148,000
Q2 2020 Sep 11, 2020	BUY	$37.87 - $43.58 $178,594 - $205,523	4,716 New	4,716 $192,000
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $208,625 - $240,082	-5,509 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $15,845 - $23,829	488 Added 9.72%	5,509 $209,000
Q4 2019 Jan 23, 2020	SELL	$42.0 - $48.25 $15,876 - $18,238	-378 Reduced 7.0%	5,021 $236,000
Q3 2019 Oct 29, 2019	SELL	$40.46 - $43.52 $5,340 - $5,744	-132 Reduced 2.39%	5,399 $230,000
Q2 2019 Aug 01, 2019	SELL	$39.4 - $42.7 $33,214 - $35,996	-843 Reduced 13.23%	5,531 $221,000
Q1 2019 May 09, 2019	SELL	$38.57 - $42.69 $99,703 - $110,353	-2,585 Reduced 28.85%	6,374 $266,000
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $338,650 - $382,459	8,959 New	8,959 $343,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.